NURS_6630_Final_Exam_6.pdf

 Question 1
0 out of 0 points
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected Answer: Yes
 Question 2
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most
appropriate for which patient with ADHD?

Selected Answer: c.
8-year-old patient
 Question 3
1 out of 1 points
Jordan is diagnosed with obsessive compulsive disorder. He has been trialed
on several different SSRIs and is currently on high dose sertraline. He reports
an inability to carry out responsibilities because of an obsession with
handwashing. Which is the best treatment option for Jordan?
Selected Answer: a.
Maintain the same dose of sertraline and add quetiapine
 Question 4
1 out of 1 points
The PMHNP is discussing dopamine D2 receptor occupancy and its association
with aggressive behaviors in patients with the student. Why does the PMHNP
prescribe a standard dose of atypical antipsychotics?

Selected c.
Answer: The doses are based on achieving 60% D2
receptor occupancy.
 Question 5
1 out of 1 points
A 72-year-old male patient is in the early stages of Alzheimer’s disease. The
PMHNP determines that improving memory is a key consideration in
selecting a medication. Which of the following would be an appropriate
choice?

Selected Answer: c.
All of these are correct

, Question 6
1 out of 1 points
A 71-year-old male patient comes to an appointment with his 65-year-old
wife. They are both having concerns related to her memory and ability to
recognize faces. The PMNHP is considering prescribing memantine
(Namenda) based on the following symptoms:

Selected Answer: c.
Amnesia, apraxia, agnosia
 Question 7
1 out of 1 points
The PMHNP is working with the student to care for a patient with diabetic
peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not
consistently useful in treating this particular patient’s pain. What is the best
response by the PMHNP?

Selected Answer: b.
“SSRIs only increase serotonin levels.”
 Question 8
1 out of 1 points
The PMHNP is caring for a patient who openly admitted to drinking a quart of
vodka daily. Prior to prescribing this patient disulfiram (Antabuse), it is
important for the PMHNP to:
Selected Answer: b.
Evaluate the patient’s willingness to abstain from alcohol
 Question 9
0 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is
receiving an initial prescription for D-amphetamine. The PMHNP
demonstrates appropriate prescribing practices when she prescribes the
following dose:

Selected Answer: a.
The child will take 10–40 mg, daily.
 Question 10
1 out of 1 points

, The PMHNP is assessing a patient who will be receiving phentermine +
topiramate combination (QSYMIA). QSYMIA would be contraindicated in
which patient?

Selected Answer: d.
A 37-year-old female that is being treated with phenelzine
 Question 11
0 out of 1 points
Jacob is a 7-year-old pediatric patient who has significant oppositional
symptoms associated with his ADHD diagnosis. What is the best treatment for
this patient?

Selected Answer: b.
Prescribe a methylphenidate alone.
 Question 12
1 out of 1 points
The PMHNP is attempting to treat a patient’s chronic pain by having the
agent bind the open channel conformation of VSCCs to block those channels
with a “use-dependent” form of inhibition. Which agent will the PMHNP
most likely select?

Selected Answer: c.
Pregabalin (Lyrica)
 Question 13
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention
deficit hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP
determines which of the following medications may be the best treatment
option?

Selected Answer: c.
Atomoxetine (Strattera)
 Question 14
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain.
How does the PMHNP anticipate the drug to work?